Physician
Abboud, Aiman
Abboud, Aiman was paid $1.11M by Medicaid between Jan 2018 and Dec 2024, across 79 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoABBOUD, AIMAN
BROOKLYN, NY 11235
BROOKLYN, NY 11235
33aNPI1063511970assigned 09/21/2006
33bProvider typeObstetrics & Gynecology Physician
28Total paid$1.11M
24GClaims46,503
24DCodes billed79
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in New York
Rank by total paid#76 of 762
Median peer was paid$22K
This provider vs. median51×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,451 | $142K | |
| 2019 | 16,271 | $243K | |
| 2020 | 5,746 | $152K | |
| 2021 | 3,944 | $143K | |
| 2022 | 4,618 | $173K | |
| 2023 | 4,313 | $148K | |
| 2024incomplete | 3,160 | $107K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 4,562 | 4,006 | $318K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14% | 3,532 | 2,814 | $158K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 1,564 | 1,468 | $152K |
| 76830 | Ultrasound, transvaginal | 13% | 1,986 | 1,920 | $140K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 5.1% | 544 | 544 | $56K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.9% | 201 | 201 | $21K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.7% | 195 | 195 | $19K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.5% | 237 | 208 | $17K |
| 81002 | 1.1% | 8,294 | 5,630 | $13K | |
| 86738 | 1.0% | 604 | 580 | $12K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 598 | 591 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 597 | 590 | $11K |
67 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 307 | $8K |
| 87510 | <1% | 627 | $7K | |
| 87480 | <1% | 627 | $7K | |
| 87660 | <1% | 626 | $7K | |
| 82670 | <1% | 270 | $6K | |
| 84403 | <1% | 256 | $6K | |
| 86703 | <1% | 601 | $6K | |
| 81025 | <1% | 2,261 | $5K | |
| 84402 | <1% | 226 | $5K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 221 | $5K |
| 84146 | <1% | 274 | $5K | |
| 82627 | <1% | 262 | $5K | |
| 86696 | <1% | 389 | $4K | |
| 87340 | <1% | 592 | $4K | |
| 83001 | <1% | 272 | $4K | |
| 86706 | <1% | 602 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 58 | $4K |
| 86376 | <1% | 380 | $4K | |
| 86709 | <1% | 601 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 51 | $4K |
| 86803 | <1% | 538 | $4K | |
| 83002 | <1% | 255 | $4K | |
| 82607 | <1% | 390 | $4K | |
| 86704 | <1% | 477 | $4K | |
| 82533 | <1% | 259 | $3K | |
| 87081 | <1% | 717 | $3K | |
| 86762 | <1% | 240 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 382 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 386 | $3K |
| 82746 | <1% | 265 | $3K | |
| 83655 | <1% | 240 | $3K | |
| 84439 | <1% | 393 | $2K | |
| 86765 | <1% | 242 | $2K | |
| 84480 | <1% | 406 | $2K | |
| 86695 | <1% | 496 | $2K | |
| 57150 | <1% | 50 | $2K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 26 | $2K |
| 82728 | <1% | 190 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 259 | $2K |
| 83525 | <1% | 202 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 54 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 587 | $2K |
| 87210 | <1% | 575 | $2K | |
| 86593 | <1% | 564 | $2K | |
| 87623 | <1% | 68 | $1K | |
| 84702 | <1% | 149 | $1K | |
| 86735 | <1% | 242 | $1K | |
| 86141 | <1% | 172 | $1K | |
| 84144 | <1% | 76 | $1K | |
| 84432 | <1% | 405 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 13 | $1K |
| 87625 | <1% | 281 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,070 | $943.33 |
| 80061 | Lipid panel | <1% | 195 | $845.57 |
| 82105 | <1% | 161 | $797.34 | |
| 83550 | <1% | 194 | $708.18 | |
| 86787 | <1% | 67 | $388.01 | |
| 85652 | <1% | 229 | $365.81 | |
| 99401 | <1% | 27 | $267.59 | |
| 86645 | <1% | 43 | $258.49 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 22 | $108.60 |
| 84481 | <1% | 12 | $95.52 | |
| 83540 | <1% | 16 | $58.98 | |
| 84436 | <1% | 259 | $4.56 | |
| 84479 | 0% | 160 | $0.00 | |
| A4550 | Surgical trays | 0% | 13 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.